What is the initial workup for a patient with elevated Dehydroepiandrosterone sulfate (DHEAS) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Workup for Elevated DHEAS Levels

The initial workup for a patient with elevated DHEAS levels should include a comprehensive hormonal evaluation focusing on adrenal function, with specific attention to ruling out adrenal tumors and other causes of adrenal hyperandrogenism. 1

Clinical Assessment

History and Physical Examination

  • Symptoms to evaluate:

    • Hirsutism, acne, virilization
    • Weight gain, central obesity
    • Menstrual irregularities (in females)
    • Hypertension, muscle weakness
    • Rapid onset of symptoms (suggests neoplasm)
    • Family history of endocrine disorders
  • Physical findings to document:

    • Pattern and extent of hirsutism
    • Signs of hypercortisolism (central obesity, striae, facial plethora)
    • Signs of virilization (clitoromegaly, male pattern baldness, deepening voice)
    • Blood pressure
    • Evidence of insulin resistance

Laboratory Evaluation

First-line Tests

  1. Complete hormonal workup:

    • Total testosterone and free testosterone
    • DHEAS (already elevated)
    • 17-OH-progesterone
    • Androstenedione
    • Morning cortisol
    • 1 mg overnight dexamethasone suppression test (DST) 1
  2. Additional tests based on clinical suspicion:

    • Aldosterone/renin ratio (if hypertensive or hypokalemic)
    • Plasma free metanephrines (to rule out pheochromocytoma)
    • 24-hour urinary free cortisol (if suspecting Cushing's syndrome)

Interpretation Guidelines

  • DHEAS >600 μg/dL strongly suggests adrenal adenoma 2
  • Total testosterone >8.7 nmol/L (250 ng/dL) warrants investigation for androgen-secreting neoplasm, though positive predictive value is only about 9% 3
  • Cortisol >138 nmol/L after 1mg DST indicates cortisol hypersecretion 1

Imaging Studies

  • Adrenal CT scan is the first-line imaging study for patients with significantly elevated DHEAS 1

    • Look for adrenal masses >1 cm
    • Assess for features suggesting malignancy (irregular margins, heterogeneity, size >4 cm)
  • Consider additional imaging if initial CT is inconclusive:

    • MRI abdomen (alternative to CT)
    • If malignancy is suspected: chest CT to evaluate for metastases

Special Considerations

For Women with Reproductive Symptoms

  • Transvaginal ultrasound to evaluate for polycystic ovaries or ovarian tumors
  • Consider pelvic MRI if ovarian pathology is suspected but ultrasound is inconclusive

For Patients with Signs of Cushing's Syndrome

  • ACTH level to differentiate ACTH-dependent from ACTH-independent causes
  • Midnight salivary cortisol
  • Confirm autonomous cortisol secretion with additional testing 1

Common Pitfalls and Caveats

  1. Not all elevated DHEAS indicates pathology:

    • DHEAS levels naturally decline with age; reference ranges should be age-adjusted
    • Only 2.3% of patients with hyperandrogenism have androgen-secreting tumors 3
    • False positives are common; only ~9% of patients with testosterone >250 ng/dL actually have neoplasms 3
  2. Consider medication effects:

    • Chronic narcotic use can lower DHEAS levels 4
    • Exogenous steroid use can suppress adrenal function
  3. Don't miss adrenal insufficiency:

    • While elevated DHEAS typically suggests excess adrenal androgen production, remember that low DHEAS can indicate adrenal insufficiency 4
    • If clinical picture suggests possible adrenal insufficiency, include ACTH stimulation test

Follow-up Recommendations

  • If initial workup is negative but DHEAS remains significantly elevated:

    • Consider referral to endocrinology
    • Periodic monitoring (every 6-12 months) with repeat DHEAS and testosterone measurements
    • Follow-up imaging if clinical symptoms worsen or hormone levels increase significantly
  • If adrenal mass is identified:

    • Follow management algorithm for adrenal incidentalomas 1
    • Consider adrenalectomy for functional tumors or those with features concerning for malignancy

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Research

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999

Guideline

Adrenal Insufficiency Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.